why choose us

First received: June 07, 2023

Clinical Trial: Topical Ruxolitinib Evaluation in Chronic Hand Eczema

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Hand Eczema

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Double-Blind, Randomized, 16-Week, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream Followed by an Open-Label Extension Period in Adults With Chronic Hand Eczema

Brief Summary: The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in adult participants with diagnosis of chronic hand eczema (CHE) and moderate to severe disease activity (Investigator's Global Assessement (IGA) of CHE score 3 or 4).

Read more